Related Experiment Video
Updated: Aug 16, 2026

08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
[Risk factors in insulin-dependent diabetes]
Pathologie-Biologie
|June 1, 1986
Summary
Identifying specific genetic markers like HLA-DR3/DR4 significantly increases the risk for insulin-dependent diabetes mellitus (IDDM). These immunogenetic factors are crucial for predicting familial risk in siblings of affected children.
Area of Science:
- Immunogenetics
- Human Genetics
- Diabetes Research
Background:
- Insulin-dependent diabetes mellitus (IDDM), also known as Type 1 diabetes, has a complex genetic component.
- Identifying specific immunogenetic markers can help understand disease susceptibility and familial risk.
Purpose of the Study:
- To calculate the relative risks (RR) of various immunogenetic markers associated with IDDM.
- To assess the role of these markers in familial disease penetrance and susceptibility.
Main Methods:
- Comparative analysis of immunogenetic markers in IDDM patients versus a control population.
- Analysis of affected and non-affected siblings of IDDM index cases, stratified by HLA-identity.
- Calculation of relative risks (RR) and statistical significance (P-values) for identified genetic associations.
Main Results:
- The combination HLA-DR3/DR4 showed the highest relative risk (RR=47) for IDDM, further elevated with RFLP cluster DQR4 (RR=72).
- In siblings, HLA-DR3 and early onset age (≤10 years) in the index case were discriminatory factors.
- Specific combinations like C4BQ0, DR3 (RR=9) and BfF1, DR3 were associated with increased familial susceptibility.
Conclusions:
- Specific immunogenetic markers, particularly HLA-DR3/DR4, are strong predictors of IDDM risk.
- Certain genetic combinations play a significant role in the familial occurrence and penetrance of IDDM.
- These findings could aid in predicting IDDM risk for siblings of diabetic children.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

